Open in App
  • U.S.
  • Election
  • Newsletter
  • optometrytimes.com

    FDA approves aflibercept-mrbb (Ahzantive), Formycon’s biosimilar to Eylea

    By Martin David Harp, Associate Editor, Ophthalmology Times,

    21 days ago
    Comments / 0
    Add a Comment
    YOU MAY ALSO LIKE
    Most Popular newsMost Popular

    Comments / 0